Literature DB >> 9882286

Transcriptional regulation of the human cytomegalovirus US11 early gene.

N H Chau1, C D Vanson, J A Kerry.   

Abstract

The human cytomegalovirus (HCMV) US11 early gene encodes a protein involved in the down-regulation of major histocompatibility complex class I cell surface expression in HCMV-infected cells. Consequently, this gene is thought to play an important role in HCMV evasion of immune recognition. In this study, we examined the transcriptional regulation of US11 gene expression. Analysis of deletions within the US11 promoter suggests that two sequence elements are important for activation by the viral immediate-early (IE) proteins. Deletion of a CREB site located at -83 relative to the cap site resulted in a reduction in promoter activity to 50% of the wild-type level. Deletion of an additional ATF site immediately upstream of the TATA box resulted in abrogation of responsiveness to the IE proteins. To confirm the role of the CREB and ATF sites within the US11 promoter, mutagenesis of these two sites, both individually and in combination, was carried out. Results indicate that both the CREB element and the ATF site were required for full promoter activity, with the ATF site critical for US11 promoter activation. The loss of transcriptional activation correlated with a loss of cellular proteins binding to the mutated US11 promoter elements. In combination with the viral IE proteins, the HCMV tegument protein pp71 (UL82) was found to up-regulate the US11 promoter by six- to sevenfold in transient assays. These results suggest that pp71 may contribute to the activation of the US11 promoter at early times after infection. Up-regulation by pp71 required the presence of the CREB and ATF sites within the US11 promoter for full activation. The role of the ATF and CREB elements in regulating US11 gene expression during viral infection was then assessed. The US11 gene is not required for replication of HCMV in tissue culture. This property was exploited to generate US11 promoter mutants regulating expression of the endogenous US11 gene in the natural genomic context. We generated recombinant HCMV that contained the US11 promoter with mutations in either the CREB or ATF element or both regulating the expression of the endogenous US11 gene. Northern blot analysis of infected cell mRNA revealed that mutation of the CREB element reduced US11 mRNA expression to approximately 25% of that of the wild-type promoter, with identical kinetics of expression. Mutation of the ATF site alone reduced US11 mRNA levels to 6% of that of the wild-type promoter, with mRNA detectable only at 8 h after infection. Mutation of both the CREB and ATF elements in the US11 promoter reduced US11 gene expression to undetectable levels. These results demonstrate that the CREB and ATF sites cooperate to regulate the US11 promoter in HCMV-infected cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882286      PMCID: PMC103905     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products.

Authors:  J A Kerry; M A Priddy; R M Stenberg
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

2.  A human cytomegalovirus early promoter with upstream negative and positive cis-acting elements: IE2 negates the effect of the negative element, and NF-Y binds to the positive element.

Authors:  L Huang; C L Malone; M F Stinski
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

3.  Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection.

Authors:  S M Rodems; C L Clark; D H Spector
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

4.  UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression.

Authors:  M Winkler; S A Rice; T Stamminger
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2.

Authors:  N Y Harel; J C Alwine
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

6.  Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain.

Authors:  R Jupp; S Hoffmann; R M Stenberg; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein.

Authors:  M H Sommer; A L Scully; D H Spector
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter.

Authors:  R Schwartz; M H Sommer; A Scully; D H Spector
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Human cytomegalovirus late protein encoded by ie2: a trans-activator as well as a repressor of gene expression.

Authors:  D E Jenkins; C L Martens; E S Mocarski
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

10.  The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation.

Authors:  R Caswell; C Hagemeier; C J Chiou; G Hayward; T Kouzarides; J Sinclair
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

View more
  19 in total

1.  UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells.

Authors:  W A Bresnahan; T E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Predicting transcription factor synergism.

Authors:  Sridhar Hannenhalli; Samuel Levy
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

3.  Interaction between the human cytomegalovirus UL82 gene product (pp71) and hDaxx regulates immediate-early gene expression and viral replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Nuclear trafficking of the human cytomegalovirus pp71 (ppUL82) tegument protein.

Authors:  Weiping Shen; Elizabeth Westgard; Liqun Huang; Michael D Ward; Jodi L Osborn; Nha H Chau; Lindsay Collins; Benjamin Marcum; Margaret A Koach; Jennifer Bibbs; O John Semmes; Julie A Kerry
Journal:  Virology       Date:  2008-04-18       Impact factor: 3.616

5.  Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication.

Authors:  Stacy R Cantrell; Wade A Bresnahan
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  Human cytomegalovirus tegument protein pp71 directs long-term gene expression from quiescent herpes simplex virus genomes.

Authors:  Chris M Preston; Mary Jane Nicholl
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Activation of the mitogen-activated protein kinase p38 by human cytomegalovirus infection through two distinct pathways: a novel mechanism for activation of p38.

Authors:  R A Johnson; S M Huong; E S Huang
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus.

Authors:  Mariana Bego; J Maciejewski; S Khaiboullina; G Pari; S St Jeor
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Authors:  Rhiannon R Penkert; Robert F Kalejta
Journal:  Future Virol       Date:  2012-09-01       Impact factor: 1.831

10.  Properties of virion transactivator proteins encoded by primate cytomegaloviruses.

Authors:  Iain P Nicholson; Jane S Sutherland; Tanya N Chaudry; Earl L Blewett; Peter A Barry; Mary Jane Nicholl; Chris M Preston
Journal:  Virol J       Date:  2009-05-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.